International Tech Times
SEE OTHER BRANDS

Your science and technology news reporter

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on June 6, 2025

Cloudera 加入 AI-RAN 聯盟推動實時數據創新和 AI 原生電訊

Cloudera 加入 AI-RAN 聯盟推動實時數據創新和 AI 原生電訊

聖塔克拉拉,加州, June 06, 2025 (GLOBE NEWSWIRE) -- 唯一真正混合數據、分析和人工智能 (AI) 的平台 Cloudera,於今天宣佈已加入 AI-RAN Alliance;AI-RAN Alliance 是一個全球性聯盟,致力於將 AI 整合到電訊基礎設施中。 Cloudera 與一群開創性的創新電訊提供商,與數據和 AI 公司攜手合作,專注於推動 AI-RAN 目標,將電訊網絡轉換為利用實時數據和 AI 的智能化、產生收入的平台。 …

Huize Holding Limited Reports First Quarter 2025 Unaudited Financial Results

Huize Holding Limited Reports First Quarter 2025 Unaudited Financial Results

SHENZHEN, China, June 06, 2025 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data- …

QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2025

QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2025

BEIJING, June 06, 2025 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading lifestyle solution provider, today announced its unaudited financial results for the third quarter of the fiscal year ending June …

Burning Rock Reports First Quarter 2025 Financial Results

Burning Rock Reports First Quarter 2025 Financial Results

GUANGZHOU, China, June 06, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today …

OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies

OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies

TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADCs) (4174. TWO), and TegMine Therapeutics, Inc. …

浩鼎自创ADC平台GlycOBI® 首宗技术合作案 携手美国TegMine开发ADC

浩鼎自创ADC平台GlycOBI® 首宗技术合作案 携手美国TegMine开发ADC

台湾, June 06, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技(以下简称「浩鼎」)(4174.TWO)今(06/06)宣布,与美国TegMine Therapeutics, Inc.(以下简称「TegMine」)签署ADC研发服务合约(Master Services Agreement, MSA);TegMine 是一家总部位于美国旧金山的生物制药公司,专注于开发针对癌症相关糖蛋白的创新抗体疗法。浩鼎则致力于开发抗癌新药及聚焦研发次世代抗体药物复合体(ADCs)。 根据合约,浩鼎将与 …

浩鼎自創ADC平台GlycOBI® 首宗技術合作案 攜手美國TegMine開發ADC

浩鼎自創ADC平台GlycOBI® 首宗技術合作案 攜手美國TegMine開發ADC

台灣, June 06, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技(以下簡稱「浩鼎」)(4174.TWO)今(06/06)宣布,與美國TegMine Therapeutics, Inc.(以下簡稱「TegMine」)簽署ADC研發服務合約(Master Services Agreement, MSA);TegMine 是一家總部位於美國舊金山的生物製藥公司,專注於開發針對癌症相關醣蛋白的創新抗體療法。浩鼎則致力於開發抗癌新藥及聚焦研發次世代抗體藥物複合體(ADCs)。 根據合約,浩鼎將與 …

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …

GPUNET Completes $4M Buyback from Early Investors, Reinforcing Long-Term Growth

GPUNET Completes $4M Buyback from Early Investors, Reinforcing Long-Term Growth

Dubai, UAE, June 05, 2025 (GLOBE NEWSWIRE) -- GPUNET has successfully completed a $4 million buyback of $GPU tokens from its early Series A investors, delivering 2-3x returns to investors who backed the project in 2022 and 2023. All buybacks were executed …

Midea Compressor Recognized: KOLs' Teardown Videos Expose Aircons' Core Component

Midea Compressor Recognized: KOLs' Teardown Videos Expose Aircons' Core Component

KUALA LUMPUR, Malaysia, June 05, 2025 (GLOBE NEWSWIRE) -- Recently, influencers from Thailand and Malaysia shared teardown reviews of air conditioners, sparking widespread discussion. Many were surprised to learn that top Japanese brands like Panasonic and …

ZenaTech lanza Drones como un Servicio (DaaS) para agencias de defensa y gobierno de EE. UU. con nuevas alianzas

ZenaTech lanza Drones como un Servicio (DaaS) para agencias de defensa y gobierno de EE. UU. con nuevas alianzas

VANCOUVER, Columbia Británica, June 05, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con inteligencia artificial (IA), Drones como un Servicio (DaaS), …

Midea's Latest Inverter Split Air Conditioner Won the German Red Dot Award

Midea's Latest Inverter Split Air Conditioner Won the German Red Dot Award

ESSEN, Germany, June 05, 2025 (GLOBE NEWSWIRE) -- Midea has won the prestigious 2025 German Red Dot Product Design Award for its Numen series air conditioners launched in Southeast Asia. The award-winning Numen incorporates Midea's latest AI ECOMASTER and …

WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the July 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired West …

Kirby McInerney LLP Reminds UroGen Pharma Ltd. (URGN) Investors of Class Action Filing and Encourages Investors to Contact the Firm

Kirby McInerney LLP Reminds UroGen Pharma Ltd. (URGN) Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who purchased UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ:URGN) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service